药品注册申请号:019594
申请类型:NDA (新药申请)
申请人:TEVA BRANDED PHARM
申请人全名:TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 ACTIGALL URSODIOL CAPSULE;ORAL 150MG No No None 1987/12/31 1987/12/31 Discontinued
002 ACTIGALL URSODIOL CAPSULE;ORAL 300MG Yes Yes AB 1987/12/31 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2023/07/19 SUPPL-37(补充) Approval Labeling STANDARD
2016/06/27 SUPPL-35(补充) Approval Manufacturing (CMC) PRIORITY
2015/10/30 SUPPL-34(补充) Approval Manufacturing (CMC) PRIORITY
2002/08/14 SUPPL-21(补充) Approval Labeling STANDARD
2002/03/15 SUPPL-13(补充) Approval Manufacturing (CMC) PRIORITY
1999/04/22 SUPPL-20(补充) Approval Manufacturing (CMC) PRIORITY
1999/04/19 SUPPL-19(补充) Approval Manufacturing (CMC) PRIORITY
1996/06/05 SUPPL-18(补充) Approval Manufacturing (CMC) PRIORITY
1996/03/29 SUPPL-16(补充) Approval Efficacy UNKNOWN
1995/09/15 SUPPL-17(补充) Approval Manufacturing (CMC) PRIORITY
1992/04/24 SUPPL-11(补充) Approval Labeling
1991/10/04 SUPPL-9(补充) Approval Manufacturing (CMC) PRIORITY
1990/10/05 SUPPL-10(补充) Approval Labeling
1989/08/02 SUPPL-7(补充) Approval Manufacturing (CMC) PRIORITY
1989/05/19 SUPPL-8(补充) Approval Labeling
1989/04/19 SUPPL-6(补充) Approval Manufacturing (CMC) PRIORITY
1989/02/14 SUPPL-1(补充) Approval Manufacturing (CMC) PRIORITY ;Orphan
1988/10/26 SUPPL-4(补充) Approval Manufacturing (CMC) PRIORITY
1988/09/30 SUPPL-5(补充) Approval Manufacturing (CMC) PRIORITY
1988/07/08 SUPPL-3(补充) Approval Labeling
1988/07/08 SUPPL-2(补充) Approval Manufacturing (CMC) PRIORITY
1987/12/31 ORIG-1(原始申请) Approval Type 1 - New Molecular Entity PRIORITY ;Orphan
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:URSODIOL 剂型/给药途径:CAPSULE;ORAL 规格:300MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
019594 002 NDA ACTIGALL URSODIOL CAPSULE;ORAL 300MG Prescription Yes Yes AB 1987/12/31 TEVA BRANDED PHARM
075517 001 ANDA URSODIOL URSODIOL CAPSULE;ORAL 300MG Prescription No No AB 2000/03/14 EPIC PHARMA
075592 001 ANDA URSODIOL URSODIOL CAPSULE;ORAL 300MG Discontinued No No AB 2000/05/25 TEVA PHARMS
079082 001 ANDA URSODIOL URSODIOL CAPSULE;ORAL 300MG Prescription No No AB 2008/12/15 LANNETT CO INC
090530 001 ANDA URSODIOL URSODIOL CAPSULE;ORAL 300MG Discontinued No No AB 2010/02/17 MYLAN
210707 001 ANDA URSODIOL URSODIOL CAPSULE;ORAL 300MG Prescription No No AB 2018/05/17 ABHAI LLC
211301 001 ANDA URSODIOL URSODIOL CAPSULE;ORAL 300MG Prescription No No AB 2018/10/16 AMNEAL PHARMS CO
212452 001 ANDA URSODIOL URSODIOL CAPSULE;ORAL 300MG Prescription No No AB 2019/10/30 EYWA PHARMA
213200 001 ANDA URSODIOL URSODIOL CAPSULE;ORAL 300MG Prescription No No AB 2020/02/12 RISING
213555 001 ANDA URSODIOL URSODIOL CAPSULE;ORAL 300MG Prescription No No AB 2020/08/17 CHARTWELL RX
214295 001 ANDA URSODIOL URSODIOL CAPSULE;ORAL 300MG Prescription No No AB 2020/10/16 ZYDUS LIFESCIENCES
210344 001 ANDA URSODIOL URSODIOL CAPSULE;ORAL 300MG Prescription No No AB 2021/01/22 STRIDES PHARMA
214329 001 ANDA URSODIOL URSODIOL CAPSULE;ORAL 300MG Prescription No No AB 2021/07/28 RK PHARMA
214849 001 ANDA URSODIOL URSODIOL CAPSULE;ORAL 300MG Prescription No No AB 2022/11/28 AUROBINDO PHARMA LTD
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database